nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CHRFAM7A—corpus luteum—hypothyroidism	0.0869	0.177	CbGeAlD
Pentobarbital—CHRNA7—corpus luteum—hypothyroidism	0.0702	0.143	CbGeAlD
Pentobarbital—GRIK2—cerebellar cortex—hypothyroidism	0.0531	0.108	CbGeAlD
Pentobarbital—CHRNA4—cochlea—hypothyroidism	0.0389	0.0792	CbGeAlD
Pentobarbital—GRIK2—nerve—hypothyroidism	0.0195	0.0397	CbGeAlD
Pentobarbital—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0193	0.0509	CcSEcCtD
Pentobarbital—Hyperkinesia—Levothyroxine—hypothyroidism	0.0193	0.0509	CcSEcCtD
Pentobarbital—CHRNA4—nerve—hypothyroidism	0.0156	0.0319	CbGeAlD
Pentobarbital—Hypotension—Liothyronine—hypothyroidism	0.015	0.0396	CcSEcCtD
Pentobarbital—CYP2C19—urine—hypothyroidism	0.0148	0.0301	CbGeAlD
Pentobarbital—Hyperkinesia—Liotrix—hypothyroidism	0.0142	0.0374	CcSEcCtD
Pentobarbital—Body temperature increased—Liothyronine—hypothyroidism	0.0127	0.0335	CcSEcCtD
Pentobarbital—Tension—Dextrothyroxine—hypothyroidism	0.00948	0.025	CcSEcCtD
Pentobarbital—Tension—Levothyroxine—hypothyroidism	0.00948	0.025	CcSEcCtD
Pentobarbital—Nervousness—Levothyroxine—hypothyroidism	0.00939	0.0248	CcSEcCtD
Pentobarbital—Nervousness—Dextrothyroxine—hypothyroidism	0.00939	0.0248	CcSEcCtD
Pentobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.009	0.0691	CbGpPWpGaD
Pentobarbital—Agitation—Dextrothyroxine—hypothyroidism	0.00888	0.0234	CcSEcCtD
Pentobarbital—Agitation—Levothyroxine—hypothyroidism	0.00888	0.0234	CcSEcCtD
Pentobarbital—Angioedema—Levothyroxine—hypothyroidism	0.00883	0.0233	CcSEcCtD
Pentobarbital—Angioedema—Dextrothyroxine—hypothyroidism	0.00883	0.0233	CcSEcCtD
Pentobarbital—CYP3A4—urine—hypothyroidism	0.00872	0.0178	CbGeAlD
Pentobarbital—Anxiety—Dextrothyroxine—hypothyroidism	0.0082	0.0216	CcSEcCtD
Pentobarbital—Anxiety—Levothyroxine—hypothyroidism	0.0082	0.0216	CcSEcCtD
Pentobarbital—Confusional state—Dextrothyroxine—hypothyroidism	0.00795	0.021	CcSEcCtD
Pentobarbital—Confusional state—Levothyroxine—hypothyroidism	0.00795	0.021	CcSEcCtD
Pentobarbital—Shock—Levothyroxine—hypothyroidism	0.00776	0.0205	CcSEcCtD
Pentobarbital—Shock—Dextrothyroxine—hypothyroidism	0.00776	0.0205	CcSEcCtD
Pentobarbital—GRIK2—heart—hypothyroidism	0.00722	0.0147	CbGeAlD
Pentobarbital—Tension—Liotrix—hypothyroidism	0.00698	0.0184	CcSEcCtD
Pentobarbital—Nervousness—Liotrix—hypothyroidism	0.00691	0.0182	CcSEcCtD
Pentobarbital—GABRA4—heart—hypothyroidism	0.0068	0.0139	CbGeAlD
Pentobarbital—Agitation—Liotrix—hypothyroidism	0.00653	0.0172	CcSEcCtD
Pentobarbital—Feeling abnormal—Levothyroxine—hypothyroidism	0.0065	0.0171	CcSEcCtD
Pentobarbital—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.0065	0.0171	CcSEcCtD
Pentobarbital—Angioedema—Liotrix—hypothyroidism	0.0065	0.0171	CcSEcCtD
Pentobarbital—Syncope—Liotrix—hypothyroidism	0.00638	0.0168	CcSEcCtD
Pentobarbital—Loss of consciousness—Liotrix—hypothyroidism	0.00625	0.0165	CcSEcCtD
Pentobarbital—Body temperature increased—Levothyroxine—hypothyroidism	0.00624	0.0164	CcSEcCtD
Pentobarbital—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00624	0.0164	CcSEcCtD
Pentobarbital—Anxiety—Liotrix—hypothyroidism	0.00603	0.0159	CcSEcCtD
Pentobarbital—CHRNA7—heart—hypothyroidism	0.00588	0.012	CbGeAlD
Pentobarbital—Confusional state—Liotrix—hypothyroidism	0.00585	0.0154	CcSEcCtD
Pentobarbital—Shock—Liotrix—hypothyroidism	0.00571	0.0151	CcSEcCtD
Pentobarbital—GABRA4—pituitary gland—hypothyroidism	0.00568	0.0116	CbGeAlD
Pentobarbital—CHRNA7—cardiovascular system—hypothyroidism	0.00555	0.0113	CbGeAlD
Pentobarbital—CHRNA4—cardiovascular system—hypothyroidism	0.00548	0.0112	CbGeAlD
Pentobarbital—CHRFAM7A—blood—hypothyroidism	0.00544	0.0111	CbGeAlD
Pentobarbital—Hypotension—Liotrix—hypothyroidism	0.00542	0.0143	CcSEcCtD
Pentobarbital—CHRFAM7A—thyroid gland—hypothyroidism	0.00525	0.0107	CbGeAlD
Pentobarbital—CHRFAM7A—female gonad—hypothyroidism	0.00507	0.0103	CbGeAlD
Pentobarbital—GABRA3—thyroid gland—hypothyroidism	0.00502	0.0102	CbGeAlD
Pentobarbital—Vomiting—Dextrothyroxine—hypothyroidism	0.00502	0.0132	CcSEcCtD
Pentobarbital—Vomiting—Levothyroxine—hypothyroidism	0.00502	0.0132	CcSEcCtD
Pentobarbital—Rash—Levothyroxine—hypothyroidism	0.00497	0.0131	CcSEcCtD
Pentobarbital—Rash—Dextrothyroxine—hypothyroidism	0.00497	0.0131	CcSEcCtD
Pentobarbital—Dermatitis—Dextrothyroxine—hypothyroidism	0.00497	0.0131	CcSEcCtD
Pentobarbital—Dermatitis—Levothyroxine—hypothyroidism	0.00497	0.0131	CcSEcCtD
Pentobarbital—Constipation—Liotrix—hypothyroidism	0.00496	0.0131	CcSEcCtD
Pentobarbital—Headache—Levothyroxine—hypothyroidism	0.00494	0.013	CcSEcCtD
Pentobarbital—Headache—Dextrothyroxine—hypothyroidism	0.00494	0.013	CcSEcCtD
Pentobarbital—GRIA2—testis—hypothyroidism	0.00493	0.0101	CbGeAlD
Pentobarbital—Feeling abnormal—Liotrix—hypothyroidism	0.00478	0.0126	CcSEcCtD
Pentobarbital—GABRG2—pituitary gland—hypothyroidism	0.00475	0.00968	CbGeAlD
Pentobarbital—Nausea—Dextrothyroxine—hypothyroidism	0.00469	0.0124	CcSEcCtD
Pentobarbital—Nausea—Levothyroxine—hypothyroidism	0.00469	0.0124	CcSEcCtD
Pentobarbital—GABRA5—testis—hypothyroidism	0.00462	0.00943	CbGeAlD
Pentobarbital—Body temperature increased—Liotrix—hypothyroidism	0.00459	0.0121	CcSEcCtD
Pentobarbital—GRIA2—cerebellum—hypothyroidism	0.00456	0.00929	CbGeAlD
Pentobarbital—CHRFAM7A—testis—hypothyroidism	0.0045	0.00917	CbGeAlD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00445	0.0342	CbGpPWpGaD
Pentobarbital—GABRA6—cerebellum—hypothyroidism	0.0044	0.00898	CbGeAlD
Pentobarbital—CHRNA7—adrenal gland—hypothyroidism	0.00439	0.00895	CbGeAlD
Pentobarbital—CHRNA7—blood—hypothyroidism	0.00439	0.00895	CbGeAlD
Pentobarbital—GABRB3—heart—hypothyroidism	0.00437	0.0089	CbGeAlD
Pentobarbital—CHRNA4—adrenal gland—hypothyroidism	0.00433	0.00883	CbGeAlD
Pentobarbital—GABRA3—testis—hypothyroidism	0.0043	0.00878	CbGeAlD
Pentobarbital—Hypersensitivity—Liotrix—hypothyroidism	0.00427	0.0113	CcSEcCtD
Pentobarbital—CHRNA7—thyroid gland—hypothyroidism	0.00424	0.00864	CbGeAlD
Pentobarbital—GRIK2—cerebellum—hypothyroidism	0.00412	0.00839	CbGeAlD
Pentobarbital—CHRNA7—female gonad—hypothyroidism	0.00409	0.00835	CbGeAlD
Pentobarbital—GABRA2—adrenal gland—hypothyroidism	0.00388	0.0079	CbGeAlD
Pentobarbital—GABRA4—cerebellum—hypothyroidism	0.00387	0.0079	CbGeAlD
Pentobarbital—Dizziness—Liotrix—hypothyroidism	0.00384	0.0101	CcSEcCtD
Pentobarbital—GABRB3—gonad—hypothyroidism	0.00374	0.00762	CbGeAlD
Pentobarbital—Vomiting—Liotrix—hypothyroidism	0.00369	0.00973	CcSEcCtD
Pentobarbital—Rash—Liotrix—hypothyroidism	0.00366	0.00965	CcSEcCtD
Pentobarbital—Dermatitis—Liotrix—hypothyroidism	0.00366	0.00964	CcSEcCtD
Pentobarbital—GABRB3—pituitary gland—hypothyroidism	0.00365	0.00744	CbGeAlD
Pentobarbital—Headache—Liotrix—hypothyroidism	0.00363	0.00959	CcSEcCtD
Pentobarbital—CHRNA7—testis—hypothyroidism	0.00363	0.0074	CbGeAlD
Pentobarbital—GABRB2—testis—hypothyroidism	0.00351	0.00715	CbGeAlD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00346	0.0266	CbGpPWpGaD
Pentobarbital—Nausea—Liotrix—hypothyroidism	0.00345	0.00909	CcSEcCtD
Pentobarbital—CYP2A6—liver—hypothyroidism	0.00343	0.00699	CbGeAlD
Pentobarbital—CYP2A6—cerebellum—hypothyroidism	0.00335	0.00683	CbGeAlD
Pentobarbital—CHRNA4—cerebellum—hypothyroidism	0.00331	0.00675	CbGeAlD
Pentobarbital—GABRB2—cerebellum—hypothyroidism	0.00324	0.00661	CbGeAlD
Pentobarbital—GABRG2—cerebellum—hypothyroidism	0.00324	0.00661	CbGeAlD
Pentobarbital—GABRB3—thyroid gland—hypothyroidism	0.00314	0.00641	CbGeAlD
Pentobarbital—GABRA2—cerebellum—hypothyroidism	0.00296	0.00604	CbGeAlD
Pentobarbital—GABRA1—cerebellum—hypothyroidism	0.00286	0.00583	CbGeAlD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00282	0.0217	CbGpPWpGaD
Pentobarbital—CYP2C19—blood—hypothyroidism	0.00282	0.00575	CbGeAlD
Pentobarbital—GABRB3—testis—hypothyroidism	0.00269	0.00549	CbGeAlD
Pentobarbital—GABRB3—liver—hypothyroidism	0.00255	0.00519	CbGeAlD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00254	0.0195	CbGpPWpGaD
Pentobarbital—GABRB3—cerebellum—hypothyroidism	0.00249	0.00507	CbGeAlD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00231	0.0177	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00223	0.0171	CbGpPWpGaD
Pentobarbital—CYP2C19—liver—hypothyroidism	0.00221	0.0045	CbGeAlD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00218	0.0167	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00198	0.0152	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—SLC5A7—hypothyroidism	0.00195	0.0149	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00194	0.0149	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00189	0.0145	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00182	0.014	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—SLC5A7—hypothyroidism	0.00177	0.0136	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00175	0.0134	CbGpPWpGaD
Pentobarbital—CYP3A4—blood—hypothyroidism	0.00167	0.0034	CbGeAlD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00167	0.0128	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00164	0.0126	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00162	0.0124	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00162	0.0124	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0016	0.0123	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00149	0.0114	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00149	0.0114	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00146	0.0112	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—SLC5A7—hypothyroidism	0.00144	0.0111	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00142	0.0109	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00139	0.0107	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00139	0.0106	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00137	0.0105	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00137	0.0105	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00136	0.0104	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00134	0.0102	CbGpPWpGaD
Pentobarbital—CYP3A4—liver—hypothyroidism	0.0013	0.00266	CbGeAlD
Pentobarbital—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.00127	0.00971	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—NEFL—hypothyroidism	0.00126	0.00963	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00125	0.00961	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00125	0.0096	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.00124	0.00951	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.00122	0.00939	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00122	0.00933	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00122	0.00932	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00119	0.00916	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00117	0.009	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00117	0.00896	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00117	0.00895	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00114	0.00878	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—NEFL—hypothyroidism	0.00114	0.00876	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00113	0.00864	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.00112	0.00859	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.00109	0.00834	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.00107	0.00819	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.00105	0.00805	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.00104	0.008	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00104	0.008	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00103	0.00789	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.00102	0.00785	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.001	0.00768	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—NEFL—hypothyroidism	0.00096	0.00737	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000941	0.00722	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—NEFL—hypothyroidism	0.000931	0.00714	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000914	0.00701	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000898	0.00689	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000894	0.00686	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000888	0.00681	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000882	0.00677	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000876	0.00672	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000861	0.0066	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.000826	0.00634	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000798	0.00613	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000788	0.00605	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000752	0.00577	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000724	0.00555	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000721	0.00553	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—NEFL—hypothyroidism	0.0007	0.00537	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000688	0.00528	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000676	0.00519	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—NEFL—hypothyroidism	0.000672	0.00515	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000666	0.00511	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000659	0.00506	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000658	0.00505	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000602	0.00462	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000584	0.00448	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000578	0.00443	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000576	0.00442	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000574	0.0044	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000564	0.00433	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00056	0.0043	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000552	0.00424	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00055	0.00422	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000545	0.00418	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000539	0.00414	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	0.000506	0.00388	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000498	0.00382	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000484	0.00372	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000481	0.00369	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000476	0.00365	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000467	0.00359	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000464	0.00356	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000456	0.0035	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000448	0.00344	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000437	0.00335	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000398	0.00306	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000329	0.00252	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—IYD—hypothyroidism	0.000274	0.0021	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000266	0.00204	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000266	0.00204	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000263	0.00202	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00024	0.00184	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000234	0.00179	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ATP5O—hypothyroidism	0.000233	0.00179	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—POMC—hypothyroidism	0.000232	0.00178	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000229	0.00176	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000225	0.00173	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000224	0.00172	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00022	0.00169	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TPO—hypothyroidism	0.000219	0.00168	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00021	0.00161	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000207	0.00159	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000198	0.00152	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000192	0.00147	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000189	0.00145	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000184	0.00141	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000181	0.00139	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000177	0.00136	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000176	0.00135	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000173	0.00133	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—IYD—hypothyroidism	0.000167	0.00128	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00016	0.00123	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000151	0.00116	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000142	0.00109	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000142	0.00109	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TPO—hypothyroidism	0.000133	0.00102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000124	0.000949	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TSHB—hypothyroidism	0.000101	0.000778	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—IYD—hypothyroidism	0.0001	0.000771	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	9.03e-05	0.000693	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ATP5O—hypothyroidism	8.54e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—POMC—hypothyroidism	8.51e-05	0.000653	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TPO—hypothyroidism	8.03e-05	0.000616	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC5A5—hypothyroidism	7.59e-05	0.000582	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TSHB—hypothyroidism	6.18e-05	0.000474	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	5.51e-05	0.000423	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.44e-05	0.000417	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A5—hypothyroidism	4.63e-05	0.000355	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—POMC—hypothyroidism	3.97e-05	0.000305	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TSHB—hypothyroidism	3.72e-05	0.000285	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.31e-05	0.000254	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.78e-05	0.000213	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—POMC—hypothyroidism	2.42e-05	0.000186	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—POMC—hypothyroidism	1.46e-05	0.000112	CbGpPWpGaD
